Emergent BioSolutions (EBS) Inventory Average (2011 - 2026)

Emergent BioSolutions' Inventory Average history runs 16 years deep, the most recent figure standing at $335.5 million for Q1 2026.

• In Q1 2026, Inventory Average rose 7.24% year-over-year to $335.5 million; the TTM figure through Mar 2026 stood at $335.5 million (up 7.24% YoY), while the FY2025 annual figure was $327.6 million, up 2.26% from the prior year.
• Inventory Average was $335.5 million for Q1 2026 at Emergent BioSolutions, down from $349.8 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $476.8 million in Q3 2022 to a low of $312.8 million in Q1 2025.
• Historically, Inventory Average has averaged $357.9 million across 5 years, with a median of $347.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Inventory Average climbed 26.99% in 2022, then dropped 25.72% in 2023.
• A 5-year view of Inventory Average shows it stood at $439.4 million in 2022, then retreated by 22.29% to $341.5 million in 2023, then declined by 7.12% to $317.2 million in 2024, then gained by 10.29% to $349.8 million in 2025, then dropped by 4.1% to $335.5 million in 2026.
• The last three Inventory Average figures came in at $335.5 million (Q1 2026), $349.8 million (Q4 2025), and $347.4 million (Q3 2025), per Business Quant data.